Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Triple Negative Breast Neoplasms 3Solid Tumor, Adult 1Colorectal Neoplasms 1

Interventions

pembrolizumab 4Proton Therapy 3toripalimab 1spartalizumab 1patritumab deruxtecan 1osimertinib 1mirdametinib 1leronlimab 1amivantamab 1Valganciclovir 1Radiotherapy 1Paclitaxel 1Lacteol 1Interleukin-2 1Docetaxel 1Carboplatin 1Blood Specimen Collection 1Bevacizumab 1BGB-283 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Solid Tumor, Adult × leronlimab × 1 year × Clear all
NCT04504942 2026-01-23

Basket Study of Leronlimab (PRO 140) in Patients With CCR5+ Locally Advanced or Metastatic Solid Tumors

CytoDyn, Inc.

Phase 2 Completed
16 enrolled 16 charts
Other solid neoplasm

Solid Tumor, Adult

Data powered by HemOnc (CC BY 4.0) Colophon âš¡